GWPH has a market cap of $3.36 billion. With the currently

New Post Public Reply Private Reply Replies (1) Message Board
GaryM truebeliever #11712
318
GWPH has a market cap of $3.36 billion. With the currently outstanding shares, our share price would be about $25 at about that market cap. In our case, I don't believe it will require having drugs approaching approval for sale, as is the case with GWPH, rather we will achieve it for product sales and simultaneously may have the same products in clinical trials.

I wish I could say how quickly this could occur, but I believe the company will consider releasing the product for sales by a variety of agents once the products have demonstrated safety, but this is my belief, not something the company committed to.

If I'm correct, I think it's possible that our cream may be available in the second quarter of 2018, and possibly the sublingual tablet by late in the year. Sales wouldn't initially give us a $3 billion market cap, but once effectiveness is clearly established anecdotally, it may not take that long to achieve. Depending on when product actually reaches the market, I wouldn't be surprised to see $20 or more within 12 months of the initiation of product sales.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 3

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 6

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 4

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 5

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 4

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 7

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 3

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 3

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading

Top 5 Most Recently Viewed Articles

Fuel Tech Q1 2025 Financial Summary: Growth and Strategy Insights

Updated Category News Views 210

Fuel Tech Celebrates a Strong Start to 2025 Fuel Tech, Inc. (NASDAQ: FTEK), a leader in technology solutions for emissions control and water treatment, has announced impressive financial results for the first quarter of 2025. The company recorded a remarkable 29% increase in revenue, reaching $6.4 million, compared to $5.0 million in the first quarter of 2024. Key...

Continue Reading
California Resources Corporation Prepares for January Conference

Updated Category News Views 76

California Resources Corporation's Upcoming January Conference California Resources Corporation (NYSE: CRC) is excited to announce its participation in two prominent investor conferences scheduled for January 2026. These events provide a unique platform for CRC's executives to engage with industry stakeholders and discuss the company’s strategic initiatives. Key Events...

Continue Reading
Cyngn Signs Intent to Deliver DriveMod Tuggers in 2025

Updated Category News Views 119

Cyngn's Letter of Intent with a Major Automotive Supplier Today, Cyngn announced that it has entered into a signed Letter of Intent (LOI) to sell and deploy multiple DriveMod Tuggers to a significant automotive supplier, set for implementation in early 2025. This agreement highlights Cyngn's persistent momentum with its Enterprise Autonomy Suite (EAS) automation solutions...

Continue Reading
Iveco Group N.V. Prepares for First Quarter Results Reveal

Updated Category News Views 147

Iveco Group N.V. Plans to Unveil Its 2025 Financial Results Iveco Group N.V. (EXM: IVG) is gearing up to release its financial performance for the first quarter of 2025 on a significant date this May. Scheduled for the 15th, this presentation is highly anticipated as it reflects the company’s market activities and financial health amidst evolving industry conditions....

Continue Reading
Anavex Life Sciences Delivers Promising Q1 Financial Results

Updated Category News Views 112

Anavex Life Sciences Delivers Promising Q1 Financial Results Anavex Life Sciences Corp. (Nasdaq: AVXL), a leading clinical-stage biopharmaceutical company, is making significant strides in developing innovative therapies for neurodegenerative diseases. The company recently presented its financial results for the first quarter of fiscal 2025, which demonstrated the ongoing...

Continue Reading